Emami Q4 FY26 Results Analysis: Revenue Slips 0.78%, EBITDA Margin Compresses 148 bps
Cofacto Research
Updated May 21, 2026
2 min read
Negative
EMAMILTD's Q4 FY26 numbers came in soft, with revenue of Rs. 3,779.51 Cr (-0.78% YoY) and PAT growth of -3.42% YoY. Here's a quick read of what worked, what to watch, and what management said.
Quick Details| Results date | May 21, 2026 |
|---|
| Quarter | Q4 FY 2025-2026 |
|---|
| Revenue (Q4) | Rs. 3,779.51 Cr (-0.78% YoY) |
|---|
| PAT (Q4) | Rs. 775.26 Cr (-3.42% YoY) |
|---|
| EBITDA margin | 25.12% (-148 bps YoY) |
|---|
| EPS (Q4) | Rs. 17.76 (-3.90% YoY) |
|---|
| Market cap | Rs. 18,206.23 Cr |
|---|
| CMP | Rs. 416.95 |
|---|
Quarter Snapshot
Emami missed its double-digit revenue growth guidance significantly (-0.78% vs double-digit target), with EBITDA margins contracting 148 bps. However, strong cash conversion (103% CFO/PAT), 50% dividend increase, and upcoming acquisitions (Axiom, IncNut) provide potential near-term catalysts. Domestic weakness (-1.8%) was partially offset by international resilience (+4.1%). FY27 outlook depends on successful integration of new acquisitions and demand recovery.
Key Investment Insights
Key Positives
- Other Income grew 25% YoY to Rs.85.11 Cr, partially offsetting revenue decline
- International business outperformed domestic with 4.1% YoY growth vs -1.8% domestic decline
- Operating cash flow strong at Rs.800.53 Cr (103.26% of PAT)
- Dividend payout increased 50% YoY to Rs.523.8 Cr
- Tax expense declined 22.3% YoY to Rs.70.81 Cr due to MAT credit utilization
- Recent acquisitions (Axiom Rs.200 Cr, IncNut Rs.321 Cr) provide FY27 growth catalysts
Risk Factors
- Revenue declined 0.78% YoY vs double-digit growth guidance - miss of ~10.8 percentage points
- EBITDA margin contracted 148 bps to 25.12% for FY26
- Domestic business declined 1.8% YoY - core market weakness
- Inventory buildup of 29.7% YoY (Rs.399.57 Cr) indicates demand uncertainty
- Subsidiaries created 8.56% drag on consolidated PAT despite 19.3% revenue contribution
- Q4 PAT declined 55.2% QoQ reflecting severe seasonality
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.
Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings
Login Now